New study finds people who have high levels of two markers at high risk of adverse heart events

New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.
Source: ScienceDaily Headlines - Category: Science Source Type: news